TERTp mutation and EGFR amplification have been reported as characteristics of IDH-wild-type GBM and as unfavourable prognostic factors in IDH-wild-type astrocytomas in many studies10–12,26, although a few studies have reported no significance14,27. This evidence concerns the gene IDH2 and glioblastoma.